Harrow Health Shares Surge Following Record Third Quarter Revenue and Earnings Beat
Harrow Health (HROW) shares rose over 14% to approximately $31.52 on Tuesday following the release of third-quarter financial results that exceeded market expectations. The company's performance was primarily driven by record revenue and significant growth within its branded eye-care product portfolio. The company reported a GAAP earnings per share (EPS) of $0.25 for the quarter, surpassing analyst estimates. This strong financial showing reflects robust demand for its specialized ophthalmic products and has provided positive momentum for the stock in recent trading sessions.
Tickers: $HROW